Retreatment and maintenance therapy with infliximab in fistulizing Crohn's disease.
Rodrigo
L
L
Service of Digestive Diseases, Hospital Central de Asturias, Oviedo, Spain. lrodrigos@terra.es
Pérez-Pariente
J M
JM
Fuentes
D
D
Cadahia
V
V
García-Carbonero
A
A
Niño
P
P
de Francisco
R
R
Tojo
R
R
Moreno
M
M
González-Ballina
E
E
D000293:Adolescent; D000328:Adult; D000368:Aged; D000465:Algorithms; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy*; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D000069285:Infliximab; D007412:Intestinal Fistula / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D008875:Middle Aged; D019233:Retreatment; D013997:Time Factors
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D000069285:Infliximab